Stergios Moschos

Neoadjuvant Treatment of Regional Stage IIIB Melanoma With High-Dose Interferon Alfa-2b Induces Objective Tumor Regression in Association With Modulation of Tumor Infiltrating Host Cellular Immune Responses

Stergios Moschos, Howard Edington, Stephanie R. Land et al. · Journal of Clinical Oncology · 2006 · 244 citations · Full text

Medicine, Immunology, Oncology +17

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

Ahmad A. Tarhini, John Cherian, Stergios Moschos et al. · Journal of Clinical Oncology · 2011 · 148 citations · Full text

Medicine, Immunology, Oncology +17

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

Jennifer Schlegel, Maria J. Sambade, Susan Sather et al. · Journal of Clinical Investigation · 2013 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +17

Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696

John M. Kirkwood, Stergios Moschos, Mark R. Albertini et al. · Clinical Cancer Research · 2009 · 139 citations · Full text

Medicine, Immunology, Oncology +17

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas

Stergios Moschos, Amanda Smith, Maja Mandić et al. · Oncogene · 2007 · 85 citations

Medicine, Molecular Biology, Oncology +17